Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bristol-Myers Q4 net sales up marginally
Net earnings were $842m for the fourth quarter of 2010, compared to $8.35bn for the same period in 2009. For the full year of 2010, net sales were
Net earnings were $842m for the fourth quarter of 2010, compared to $8.35bn for the same period in 2009. For the full year of 2010, net sales were
For the fourth quarter of 2010, Lilly’s operating income was $1.45bn, compared to $1.21bn for the same period in 2009. Eli Lilly has generated a net income of
PureNano combines a machine with expert process development to obtain smaller and more consistent particle sizes for several applications including pharmaceutical and energy industries. The PureNano Continuous Crystallizer
The agreements cover the manufacture of TMC278 as a single agent medicine and a license to develop an FDC product using TMC278 with 300mg tenofovir disoproxil fumarate and
The company has posted a net loss of $14.23m for the second quarter 2010, or $0.21 per diluted share, compared to net loss of $13m, or $0.23 per
The results of a pre-specified analysis in patients treated in the second- and third-line setting showed an improvement in overall survival and progression-free survival. The overall safety analysis
The first Phase I clinical trial is a single-ascending dose study in 32 healthy volunteers, while the second trial is a multiple-ascending dose study in 32 RA patients
According to the company, the Berinert marketing approval is given on the basis of positive results from Phase II/III prospective, double-blind placebo-controlled International Multi-center Prospective Angioedema C1-Inhibitor Trial
NCPDP’s new product will give subscribers timely access to legislative intelligence, as well as customized reports to analyze and track key developments in pharmacy legislation. NCPDP’s customized State
UPEI and AVRF under the collaboration have formed a new compound resulting in the chemical combination of 2 distinct nutraceuticals. UPEI chairman Tarek Saleh said ongoing research suggests